We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$564M
AUM Growth
+$34.3M
Cap. Flow
-$3.12M
Cap. Flow %
-0.55%
Top 10 Hldgs %
22.8%
Holding
982
New
716
Increased
64
Reduced
181
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 13.25%
2 Healthcare 12.42%
3 Financials 12.23%
4 Industrials 9.48%
5 Consumer Discretionary 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DELL icon
651
Dell
DELL
$243B
$15K ﹤0.01%
+581
New +$15.5K
FBRX icon
652
Forte Biosciences
FBRX
$1.57B
$15K ﹤0.01%
+3
New +$11.4K
IXC icon
653
iShares Global Energy ETF
IXC
$2.72B
$15K ﹤0.01%
+403
New +$14.9K
RDNT icon
654
RadNet
RDNT
$4.89B
$15K ﹤0.01%
+1,000
New +$14.3K
ADI icon
655
Analog Devices
ADI
$179B
$14K ﹤0.01%
+152
New +$14.6K
AKAM icon
656
Akamai
AKAM
$16.1B
$14K ﹤0.01%
+200
New +$15K
FLOT icon
657
iShares Floating Rate Bond ETF
FLOT
$10.2B
$14K ﹤0.01%
+278
New +$14.2K
PJP icon
658
Invesco Pharmaceuticals ETF
PJP
$446M
$14K ﹤0.01%
+200
New +$14.4K
PNR icon
659
Pentair
PNR
$10.7B
$14K ﹤0.01%
+342
New +$14.8K
SNAP icon
660
Snap
SNAP
$7.86B
$14K ﹤0.01%
+1,685
New +$19.6K
SUN icon
661
Sunoco
SUN
$14.3B
$14K ﹤0.01%
+500
New +$13.5K
TRU icon
662
TransUnion
TRU
$16.6B
$14K ﹤0.01%
+200
New +$14.9K
WDAY icon
663
Workday
WDAY
$39.2B
$14K ﹤0.01%
+100
New +$13.9K
VGR
664
DELISTED
Vector Group Ltd.
VGR
$14K ﹤0.01%
+1,546
New +$16.8K
CS
665
DELISTED
Credit Suisse Group
CS
$14K ﹤0.01%
+1,000
New +$15.2K
PTLA
666
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$14K ﹤0.01%
+545
New +$17.8K
FLY
667
DELISTED
Fly Leasing Limited
FLY
$14K ﹤0.01%
+1,000
New +$14.1K
CY
668
DELISTED
Cypress Semiconductor
CY
$14K ﹤0.01%
+1,000
New +$16.5K
GOLD
669
DELISTED
Randgold Resources Ltd
GOLD
$14K ﹤0.01%
+209
New +$14.4K
ARE icon
670
Alexandria Real Estate Equities
ARE
$9.31B
$13K ﹤0.01%
+110
New +$13.9K
AZN icon
671
AstraZeneca
AZN
$267B
$13K ﹤0.01%
+170
New +$12.9K
BRKL
672
DELISTED
Brookline Bancorp
BRKL
$13K ﹤0.01%
+800
New +$14.5K
BSX icon
673
Boston Scientific
BSX
$69.5B
$13K ﹤0.01%
+363
New +$12.7K
DEM icon
674
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.84B
$13K ﹤0.01%
+300
New +$13.1K
DG icon
675
Dollar General
DG
$27.8B
$13K ﹤0.01%
+124
New +$12.9K

Similar funds

Girard Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Girard Partners held 982 positions worth $564M, up 6.5% from $530M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Girard Partners's Q3 2018 filing shows 716 new, 64 increased, 181 reduced and 3 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 5,985 shares worth $408K. The largest sale was Apple, an estimated $2.54M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Girard Partners's largest Q3 2018 buy was Invesco Zacks Mid-Cap ETF: 5,985 shares worth $408K.
  • Girard Partners added most to State Street SPDR Portfolio S&P 500 ETF in Q3 2018, an estimated $1.7M increase.
  • Girard Partners's biggest Q3 2018 reduction was Apple, cutting an estimated $2.54M.
  • Girard Partners fully exited Athenex, Inc. Common Stock in Q3 2018, selling an estimated $940K.
  • Girard Partners's ten largest holdings make up 23% of its $564M portfolio in Q3 2018.
  • Girard Partners opened 716 new positions and closed 3 in Q3 2018.
  • Girard Partners's portfolio value rose 6.5% quarter-over-quarter to $564M.

Based on Girard Partners's 13F filing for Q3 2018, filed 9 Nov 2018.